Valley National Advisers’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Valley National Advisers’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-147	Closed	-$4K	–	1267
2023 Q3	$4K	Hold	147	–	–	﹤0.01%	741
2023 Q2	$5K	Hold	147	–	–	﹤0.01%	691
2023 Q1	$4K	Hold	147	–	–	﹤0.01%	706
2022 Q4	$4K	Hold	147	–	–	﹤0.01%	692
2022 Q3	$4K	Hold	147	–	–	﹤0.01%	718
2022 Q2	$5K	Sell	147 -1,906	-93%	-$54.4K	﹤0.01%	668
2022 Q1	$69K	Sell	2,053 -930	-31%	-$32.2K	0.01%	329
2021 Q4	$126K	Sell	2,983 -1,285	-30%	-$57.3K	0.02%	266
2021 Q3	$194K	Sell	4,268 -32	-0.7%	-$1.47K	0.04%	222
2021 Q2	$210K	Sell	4,300 -187	-4%	-$8.96K	0.04%	215
2021 Q1	$226K	Sell	4,487 -17,301	-79%	-$958K	0.04%	202
2020 Q4	$1.12M	Buy	21,788 +9,535	+78%	+$454K	0.23%	95
2020 Q3	$504K	Buy	12,253 +3,434	+39%	+$142K	0.12%	129
2020 Q2	$369K	Buy	+8,819	New	+$348K	0.09%	139

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Valley National Advisers's SBIO Position: Q4 2023 in Review

Valley National Advisers sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2023, closing a stake of 147 shares — an estimated $4K sold.

Valley National Advisers first reported a position in SBIO in Q2 2020 and held it in 14 quarters. The position peaked at $1.12M in Q4 2020. 34 funds tracked by Wall St. Rank hold SBIO as of Q4 2023.

Valley National Advisers reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2023 after selling out during the quarter.
Valley National Advisers sold 147 ALPS Medical Breakthroughs ETF shares in Q4 2023, an estimated $4K.
Valley National Advisers first reported a position in ALPS Medical Breakthroughs ETF in Q2 2020 and held it in 14 quarters.
Valley National Advisers's ALPS Medical Breakthroughs ETF position peaked at $1.12M in Q4 2020.
34 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2023.

Based on Valley National Advisers's 13F filing for Q4 2023, filed 25 Jan 2024.